Diagnosis of mast cell activation syndrome: a global "consensus-2".

The document discusses the growing recognition of mast cell activation syndrome (MCAS) and the two main diagnostic criteria proposed for its diagnosis, termed "consensus-1" and "consensus-2." It highlights the differences in these proposals and addresses the potential for overdiagnosis with "consensus-2" and underdiagnosis with "consensus-1." Given the increasing recognition that MCAS may affect up to 17% of the general population and the potential benefits of treatment, the authors suggest that diagnosing MCAS using either set of criteria is currently valid and beneficial until more definitive research is conducted.

Diagnosis / Diagnostic Criteria
Published April 24, 2020
Diagnosis of mast cell activation syndrome: a global
Contributors
Source

Diagnosis (Berlin, Germany)

Medical Disclaimer

The purpose of this website is to inform and educate only. The information provided here is not intended to serve as professional medical advice, diagnosis, or treatment.

If you have health related issues, please contact a qualified health professional to get the personalized assessment, advice, and treatment that you need.

The creators of this living library, documentary and/or website will not be liable for any direct, indirect, or other damages arising from the use of these resources.